Altered B cell receptor signaling in human systemic lupus erythematosus
about
Targeted therapeutics in SLE: emerging strategies to modulate the interferon pathwayPolychromatic flow cytometry in evaluating rheumatic disease patientsThe pathogenesis of systemic lupus erythematosus—an updateLipid anti-lipid antibody responses correlate with disease activity in systemic lupus erythematosusB-Cell and Monocyte Contribution to Systemic Lupus Erythematosus Identified by Cell-Type-Specific Differential Expression Analysis in RNA-Seq Data.Systems biology of lupus: mapping the impact of genomic and environmental factors on gene expression signatures, cellular signaling, metabolic pathways, hormonal and cytokine imbalance, and selecting targets for treatment.T-cell and B-cell signaling biomarkers and treatment targets in lupus.Rationale for B cell targeting in SLEActivation-induced necroptosis contributes to B-cell lymphopenia in active systemic lupus erythematosus.SLE peripheral blood B cell, T cell and myeloid cell transcriptomes display unique profiles and each subset contributes to the interferon signatureActivation-induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis.Evidence of dynamically dysregulated gene expression pathways in hyperresponsive B cells from African American lupus patients.Pathogenesis and potential therapeutic targets in systemic lupus erythematosus: from bench to bedsideEffect of Leflunomide on the Abnormal Expression of Lipid Rafts and F-Actin in B Lymphocytes from Patients with Systemic Lupus ErythematosusAdvances in human B cell phenotypic profiling.The transcription factors Egr2 and Egr3 are essential for the control of inflammation and antigen-induced proliferation of B and T cells.Altered AKT1 and MAPK1 gene expression on peripheral blood mononuclear cells and correlation with T-helper-transcription factors in systemic lupus erythematosus patientsMulticenter retrospective analysis of the effectiveness and safety of rituximab in korean patients with refractory systemic lupus erythematosus.The structural wedge domain of the receptor-like tyrosine phosphatase CD45 enforces B cell tolerance by regulating substrate specificity.Activation of TLR7 increases CCND3 expression via the downregulation of miR-15b in B cells of systemic lupus erythematosus.Single-cell network profiling (SCNP) by flow cytometry in autoimmune disease.Aberrant B cell selection and activation in systemic lupus erythematosus.B-cell hyperactivity in primary Sjögren's syndrome.Phosphorothioate-modified CpG oligodeoxynucleotides mimic autoantigens and reveal a potential role for Toll-like receptor 9 in receptor revision.Lupus nephritis and B-cell targeting therapy.Hydroxychloroquine in systemic lupus erythematosus (SLE).Calcium Signaling: From Normal B Cell Development to Tolerance Breakdown and Autoimmunity.SERPINB3 expression on B-cell surface in autoimmune diseases and hepatitis C virus-related chronic liver infection.PKK deficiency in B cells prevents lupus development in Sle lupus mice.CircIBTK inhibits DNA demethylation and activation of AKT signaling pathway via miR-29b in peripheral blood mononuclear cells in systemic lupus erythematosus.
P2860
Q26746697-A353A0FF-7D97-4267-B4A6-7479456DC79AQ26827075-A470CEE7-46E0-4EBF-B65B-FDD30DF1E704Q29394347-49BA7A03-B637-4D13-BF10-755C236BF0BBQ30588683-F7B6D7D9-5042-4F1D-923C-959D55A3B37DQ31012687-13F62773-21BC-418B-AC64-60D3130A7FF0Q33608479-77220750-F4DB-40FC-BBCD-6A551569A5F7Q33718893-D86984F7-0584-47A1-B7B3-CAA508638640Q33829700-CDF1FF0B-2480-4922-AD20-69A446F51739Q34476578-F8C706D2-63C3-4737-940C-BEB08D6A2964Q34796327-95C0F0B6-4298-4648-B9C6-2A6E7C917864Q34816243-F140F84B-6BB6-41B6-A926-10E1AE1A46A9Q34971055-C2FE2D68-DD23-4E90-A68F-883BA226F14AQ35309470-52BF6333-472D-45CF-B1F3-C49243C28E09Q35674006-73FF9701-46B1-4926-BAF1-008A3871B37BQ36307080-1BE3A0A5-7B77-4AF1-9A8E-6FA67A477C81Q36335917-95444CF9-7D54-47A3-8601-9FB28095030DQ36355671-24980AE0-ABB5-427B-AF6A-D71B33D9015FQ36469965-B0A51B8B-DDBA-47A9-A886-516D62787127Q36672815-0BFEA3DC-B435-4BAD-A294-2C90B94D21E2Q37402436-AF9B1571-4EF5-46E2-A8BF-D53C2BAE09C6Q37756172-794951F3-327B-4569-B0D1-41D6BB3420F7Q38114501-F1CA745D-83B0-438A-9574-5F935FE9EB93Q38190590-93878B2F-FDE3-4D12-A3BF-E5A72F8E0920Q38318807-5623E19B-DEA6-43DA-8028-403764BDB907Q38643755-AADD8114-9D06-402B-A40B-7F7189E95DD6Q39031764-158AA937-30CB-4CCA-87B6-061734F33B1AQ39303549-EA8D26E0-DF68-4333-B652-F1522A1D290FQ45355954-65BD9FE1-B512-4B1B-BDD6-69FC36662985Q50678340-5729E498-FE44-4D8F-8160-63084DDEA17DQ55476959-4006E295-5222-4868-AEF1-C65B37BA4C3E
P2860
Altered B cell receptor signaling in human systemic lupus erythematosus
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Altered B cell receptor signaling in human systemic lupus erythematosus
@en
Altered B cell receptor signaling in human systemic lupus erythematosus.
@nl
type
label
Altered B cell receptor signaling in human systemic lupus erythematosus
@en
Altered B cell receptor signaling in human systemic lupus erythematosus.
@nl
prefLabel
Altered B cell receptor signaling in human systemic lupus erythematosus
@en
Altered B cell receptor signaling in human systemic lupus erythematosus.
@nl
P2860
P1433
P1476
Altered B cell receptor signaling in human systemic lupus erythematosus
@en
P2093
Iñaki Sanz
Scott A Jenks
P2860
P304
P356
10.1016/J.AUTREV.2008.07.047
P577
2008-08-22T00:00:00Z